Trial Details
TERMINATEDBasic Information
| Clinical ID | c1775 |
|---|---|
| Identifier | NCT01562951 |
| Trial Title | Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease|Mucosal Inflammation |
| Interventions | DRUG: ADALIMUMAB|DRUG: Placebo |
Participant Information
| Sponsor | Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa |
|---|---|
| City | Bonheiden |
| Country/Region | Belgium |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-10-12 |
|---|---|
| Primary Completion Date | 2025-03-14 |
| Completion Date | 2025-03-14 |